Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Por Spitaleri, Gianluca, Biffi, Roberto, Barberis, Massimo, Fumagalli, Caterina, Toffalorio, Francesca, Catania, Chiara, Noberasco, Cristina, Lazzari, Chiara, de Marinis, Filippo, De Pas, Tommaso
Publicado no Onco Targets Ther (2015)

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E

Por Catania, Chiara, Conforti, Fabio, Spitaleri, Gianluca, Barberis, Massimo, Preda, Lorenzo, Noberasco, Cristina, Lazzari, Chiara, Toffalorio, Francesca, de Marinis, Filippo, Manzotti, Michela, De Pas, Tommaso Martino
Publicado em 2014

Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations

Por Bertani, Emilio, Testori, Alessandro, Chiappa, Antonio, Misitano, Pasquale, Biffi, Roberto, Viale, Giuseppe, Mazzarol, Giovanni, De Pas, Tommaso, Botteri, Edoardo, Contino, Gianmarco, Verrecchia, Francesco, Bazolli, Barbara, Andreoni, Bruno
Publicado em 2012

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Por Federico, Rea, Adolfo, Favaretto, Giuseppe, Marulli, Lorenzo, Spaggiari, Martino, DePas Tommaso, Anna, Ceribelli, Adriano, Paccagnella, Gino, Crivellari, Francesca, Russo, Matteo, Ceccarelli, Gbenga, Kazeem, Paolo, Marchi, Francesco, Facciolo
Publicado em 2013

Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

Por Marchetti, Antonio, Del Grammastro, Maela, Felicioni, Lara, Malatesta, Sara, Filice, Giampaolo, Centi, Irene, De Pas, Tommaso, Santoro, Armando, Chella, Antonio, Brandes, Alba Ariela, Venturino, Paola, Cuccurullo, Franco, Crinò, Lucio, Buttitta, Fiamma
Publicado em 2014

Complex renal cysts associated with crizotinib treatment

Por Schnell, Patrick, Bartlett, Cynthia H, Solomon, Benjamin J, Tassell, Vanessa, Shaw, Alice T, de Pas, Tommaso, Lee, Soo-Hyun, Lee, Geon Kook, Tanaka, Kaoru, Tan, Weiwei, Tang, Yiyun, Wilner, Keith D, Safferman, Allan, Han, Ji-Youn
Publicado no Cancer Med (2015)

Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets

Por Toffalorio, Francesca, Spitaleri, Gianluca, Catania, Chiara, Dal Zotto, Laura, Noberasco, Cristina, Delmonte, Angelo, Santarpia, Mariacarmela, Vecchio, Fabio, Brunelli, Veronica, Rampinelli, Cristiano, Barberis, Massimo, Fumagalli, Caterina, Zucchetti, Massimo, Zangarini, Monique, Diena, Tullia, Danesi, Romano, de Braud, Filippo, De Pas, Tommaso
Publicado em 2014

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

Por Vansteenkiste, Johan F., Canon, Jean-Luc, De Braud, Filippo, Grossi, Francesco, De Pas, Tommaso, Gray, Jhanelle E., Su, Wu-Chou, Felip, Enriqueta, Yoshioka, Hiroshige, Gridelli, Cesare, Dy, Grace K., Thongprasert, Sumitra, Reck, Martin, Aimone, Paola, Vidam, Gena Atalla, Roussou, Pantelia, Wang, Ying A., Tomaso, Emmanuelle Di, Soria, Jean-Charles
Publicado no J Thorac Oncol (2015)

Intracranial and whole-body response of ceritinib in ALK inhibitor-naïve and previously ALK inhibitor-treated patients with ALK-rearranged non-small-cell lung cancer (NSCLC): updat...

Por Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S W, Felip, Enriqueta, Chow, Laura Q M, Camidge, D Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J, Solomon, Benjamin J, Wolf, Jürgen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Sutradhar, Santosh, Li, Siyu, Szczudlo, Tomasz, Yovine, Alejandro, Shaw, Alice T
Publicado no Lancet Oncol (2016)

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Por Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
Publicado em 2014

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Por Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y., Goldwasser, Meredith, Boral, Anthony L., Engelman, Jeffrey A.
Publicado em 2014